James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 51,100 shares at $206.05 ($10.5M) on 2021-01-19, disclosed to the SEC on 2021-01-20.
Open-market sale of $10.5M CRSP by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $203.58 | 6,785 | $1.4M | 13.2% |
| 2 | $203.58 | 6,785 | $1.4M | 13.2% |
| 3 | $204.40 | 7,818 | $1.6M | 15.3% |
| 4 | $204.40 | 7,818 | $1.6M | 15.3% |
| 5 | $205.60 | 8,997 | $1.8M | 17.7% |
| 6 | $205.60 | 8,997 |
| $1.8M |
| 17.7% |
| 7 | $206.05 | 1,800 | $371K | 3.5% |
| 8 | $207.61 | 2,100 | $436K | 4.2% |
| Total | $204.79 avg | 51,100 | $10.5M | 100% |
| Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |